According to Sequent Scientific latest financial reports the cash on hand of SEQUENT is $4.96M, an decrease of -29.59% to 2022. At the end of 2022 company had $7.05M cash on hand. This amount reflects the liquid assets available to the company, which are crucial for its operational flexibility, investment opportunities, and overall financial security.
Year | Cash on Hand | Change |
---|---|---|
2023 | $4.96M | -29.59% |
2022 | $7.05M | -0.97% |
2021 | $7.12M | -44.86% |
2020 | $12.91M | 58.62% |
2019 | $8.14M | - |